» Articles » PMID: 25101600

The Role of Palliative Resection for Asymptomatic Primary Tumor in Patients with Unresectable Stage IV Colorectal Cancer

Overview
Specialty Gastroenterology
Date 2014 Aug 8
PMID 25101600
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The prognostic role of surgical resection of primary tumors is not well established in patients with asymptomatic unresectable stage IV colorectal cancer.

Objective: The aims of this study were to reveal the prognostic role of surgical resection of primary tumors and to define prognostic factors affecting long-term oncological outcomes in patients with asymptomatic unresectable synchronous metastases.

Design: This study was a retrospective analysis of prospectively collected data.

Patients: Between 2000 and 2008, a total of 416 patients with asymptomatic unresectable stage IV colorectal cancer were analyzed with propensity score matching.

Main Outcome Measures: Prematching baseline characteristics were compared by bivariate analysis, and 113 pairs were selected after 1:1 matching with propensity scores estimated from logistic regression. The primary end point was overall survival.

Results: Among 416 patients, 218 (52.4%) underwent palliative resection of the primary tumor. Before propensity score matching, palliative resection resulted in a better survival rate than nonresection in univariate analysis (p < 0.001), but not in multivariate analysis (p = 0.08). After matching, the 5-year overall survival rate was significantly lower for patients with peritoneal metastasis and clinical M1b stage tumors in univariate analysis (p = 0.004 and p = 0.02). However, neither peritoneal metastasis nor clinical M1b stage showed any prognostic significance in multivariate analysis. The overall 5-year survival rate of the postmatching group was 4.9% and 3.5% in the palliative resection and nonresection groups. Consequently, palliative resection was not associated with a significant increase in survival compared with nonresection (p = 0.27). A subgroup analysis performed according to the site of metastasis also did not show any significant survival benefit of palliative resection after matching.

Limitations: Selection bias and potential confounders were limitations of this study.

Conclusions: Resection of the primary tumor in patients with asymptomatic unresectable stage IV colorectal cancer was not associated with an improvement in overall survival after propensity score matching.

Citing Articles

Primary tumor resection might improve outcomes in metastatic thoracic esophageal cancer.

Wu J, Zheng H, Wang G, Qin F, Zheng Y, Chen J Sci Rep. 2025; 15(1):3054.

PMID: 39856122 PMC: 11760341. DOI: 10.1038/s41598-025-85419-y.


Primary tumor resection for asymptomatic colorectal cancer patients with synchronous unresectable metastases: a meta-analysis of randomized controlled trials and case-matched studies.

Huang J, Zhou J, Zhang P, Wu Q, Wang Z Langenbecks Arch Surg. 2024; 409(1):242.

PMID: 39105876 PMC: 11303460. DOI: 10.1007/s00423-024-03414-9.


Palliative primary tumor resection may not offer survival benefits for patients with unresectable metastatic colorectal neuroendocrine neoplasms, one multicenter retrospective cohort study.

Yu G, Liu S, Wang Z, Liu Q, Ren H, Hu W BMC Surg. 2024; 24(1):85.

PMID: 38475759 PMC: 10936098. DOI: 10.1186/s12893-024-02380-9.


Clinical Outcomes of Upfront Primary Tumor Resection in Synchronous Unresectable Metastatic Colorectal Cancer.

Shin J, An H, Shim B, Kim H, Park H, Cho H Cancers (Basel). 2023; 15(20).

PMID: 37894424 PMC: 10605032. DOI: 10.3390/cancers15205057.


The impact of primary tumor resection for asymptomatic colorectal cancer patients with unresectable metastases: a systematic review and meta-analysis.

Li S, Ji L, Huang J, Wang Y, Liu P, Zhang W Int J Colorectal Dis. 2023; 38(1):214.

PMID: 37581775 DOI: 10.1007/s00384-023-04500-y.